Companies › Eli Lilly › Revenue

Eli Lilly revenue, 2008–2025

Eli Lilly reported revenue of $65.2 billion for the fiscal year ended Dec. 31, 2025, up 44.7% from $45.0 billion the year before, according to its Form 10-K.

$65.2Blatest fiscal year (ended Dec. 31, 2025)
+44.7%change from the year before
$65.2Bhighest year shown (2025)
2008: $20.4B ’08 2009: $21.8B 2010: $23.1B ’10 2011: $24.3B 2012: $22.6B ’12 2013: $23.1B 2014: $19.6B ’14 2015: $20.0B 2016: $21.2B ’16 2017: $20.0B 2018: $21.5B ’18 2019: $22.3B 2020: $24.5B ’20 2021: $28.3B 2022: $28.5B ’22 2023: $34.1B 2024: $45.0B ’24 2025: $65.2B ’25

Fiscal years labeled by the year in which they ended. Bars drawn from the table below.

Eli Lilly revenue by fiscal year

Fiscal year endedRevenueChangeFiling
Dec. 31, 2025 $65.2B +44.7% 10-K (2026) ↗
Dec. 31, 2024 $45.0B +32.0% 10-K (2026) ↗
Dec. 31, 2023 $34.1B +19.6% 10-K (2026) ↗
Dec. 31, 2022 $28.5B +0.8% 10-K (2025) ↗
Dec. 31, 2021 $28.3B +15.4% 10-K (2024) ↗
Dec. 31, 2020 $24.5B +9.9% 10-K (2023) ↗
Dec. 31, 2019 $22.3B +3.8% 10-K (2022) ↗
Dec. 31, 2018 $21.5B +7.6% 10-K (2021) ↗
Dec. 31, 2017 $20.0B −5.9% 10-K (2020) ↗
Dec. 31, 2016 $21.2B +6.3% 10-K (2019) ↗
Dec. 31, 2015 $20.0B +1.7% 10-K (2018) ↗
Dec. 31, 2014 $19.6B −15.1% 10-K (2017) ↗
Dec. 31, 2013 $23.1B +2.3% 10-K (2016) ↗
Dec. 31, 2012 $22.6B −6.9% 10-K (2015) ↗
Dec. 31, 2011 $24.3B +5.2% 10-K (2014) ↗
Dec. 31, 2010 $23.1B +5.7% 10-K (2013) ↗
Dec. 31, 2009 $21.8B +7.2% 10-K (2012) ↗
Dec. 31, 2008 $20.4B — 10-K (2011) ↗

Other Eli Lilly financials

Net incomeDiluted EPSR&D expenseOperating cash flowDividends per shareDiluted sharesTotal assetsCash and equivalentsStockholders' equity Quarterly results and next earnings date Eli Lilly company hub

FAQ

Q What was Eli Lilly's revenue in its latest fiscal year?

A Eli Lilly reported revenue of $65.2 billion for the fiscal year ended Dec. 31, 2025, up 44.7% from $45.0 billion the year before, according to its Form 10-K.

Q What is Eli Lilly's highest annual revenue on record here?

A $65.2 billion, in the fiscal year ended Dec. 31, 2025, among the fiscal years 2008–2025 reported in its 10-K XBRL data.

Q Where does this revenue data come from?

A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Total revenue as reported in the 10-K income statement (net of interest expense for banks).

Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Total revenue as reported in the 10-K income statement (net of interest expense for banks). For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.